COLITIS, ULCERATIVE
Clinical trials for COLITIS, ULCERATIVE explained in plain language.
Never miss a new study
Get alerted when new COLITIS, ULCERATIVE trials appear
Sign up with your email to follow new studies for COLITIS, ULCERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gut bacteria treatment for ulcerative colitis shows promise in early trial
Disease control TerminatedThis study tested an experimental treatment called VE202 in 114 people with mild-to-moderate ulcerative colitis. The goal was to see if VE202 could reduce inflammation in the colon and improve symptoms compared to a placebo. The trial was stopped early, but the results help resea…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control TerminatedThis study tested whether a daily tablet called VTX002 can safely help people with moderate to severe ulcerative colitis (UC) feel better and reduce gut inflammation. About 213 adults with UC took either a low dose, a high dose, or a placebo pill for 13 weeks, with some continuin…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Oppilan Pharma Ltd • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
Ulcerative colitis drug study halted early
Disease control TerminatedThis study looked at the safety and effectiveness of ozanimod, a daily pill, for people with moderate to severe ulcerative colitis. It aimed to see if the drug could reduce symptoms like diarrhea and rectal bleeding and improve quality of life. The study was terminated early, so …
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:55 UTC